GC Cell Corporation

KOSDAQ:A144510 Rapporto sulle azioni

Cap. di mercato: ₩477.9b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

GC Cell Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

James Park

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEO0.1%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneNessun dato

Aggiornamenti recenti sulla gestione

Recent updates

Is GC Cell (KOSDAQ:144510) A Risky Investment?

Sep 08
Is GC Cell (KOSDAQ:144510) A Risky Investment?

We Think Green Cross Lab Cell's (KOSDAQ:144510) Robust Earnings Are Conservative

Mar 19
We Think Green Cross Lab Cell's (KOSDAQ:144510) Robust Earnings Are Conservative

We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt

Feb 22
We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt

Can Green Cross Lab Cell Corporation (KOSDAQ:144510) Improve Its Returns?

Jan 18
Can Green Cross Lab Cell Corporation (KOSDAQ:144510) Improve Its Returns?

Can You Imagine How Jubilant Green Cross Lab Cell's (KOSDAQ:144510) Shareholders Feel About Its 139% Share Price Gain?

Dec 14
Can You Imagine How Jubilant Green Cross Lab Cell's (KOSDAQ:144510) Shareholders Feel About Its 139% Share Price Gain?

AMMINISTRATORE DELEGATO

James Park (58 yo)

no data

Mandato

Mr. James Park is Chairman of the Board of BioCentriq, Inc and was its Interim CEO. He had been a Director of Artiva Biotherapeutics, Inc. since January 2023 until July 2024. He served as Executive VP at S...